ORGENESIS
Live / Applied — Second extension granted (statement of use) (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 24 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98373717
- Mark type
- Stylized text
- Filed
- 24 Jan 2024
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Jacqueline Zion
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer, infectious diseases, auto-immune diseases, metabolic disorders, dermatological diseases and disorders, musculoskeletal disorders
Owner
- Orgenesis Inc., Germantown, MD, US
- Orgenesis Inc., Germantown, MD, US
Prosecution history
- 24 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 2 GRANTED
- 02 Dec 2025 — SOU EXTENSION 2 FILED
- 18 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 18 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 18 Feb 2026 — PETITION TO REVIVE-GRANTED
- 18 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 05 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2025 — SOU EXTENSION 1 GRANTED
- 02 Jun 2025 — SOU EXTENSION 1 FILED
- 05 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Sept 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 08 Sept 2025 — NOTICE OF REVIVAL - E-MAILED